Evidence map›Paper›PMID 38904377›Full record

ArticlemSystems2024

Genomic insights into the evolution of secondary metabolism of

Aileen Berasategui, Hassan Salem, Abraham G Moller, Yuliana Christopher, Quimi Vidaurre Montoya, Caitlin Conn, Timothy D Read, Andre Rodrigues, Nadine Ziemert, Nicole Gerardo

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aileen BerasateguiDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-7317-8139
Hassan SalemDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-4135-7407
Abraham G MollerDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Yuliana ChristopherInstituto de Investigaciones Científicas y Servicios de Alta Tecnología, Ciudad del Saber, Panamá City, Panama.
Quimi Vidaurre MontoyaDepartment of General and Applied Biology, São Paulo State University (UNESP), Institute of Biosciences, Rio Claro, São Paulo, Brazil.ORCID 0000-0002-3285-5981
Caitlin ConnDepartment of Biology, Emory University, Atlanta, Georgia, USA.
Timothy D ReadDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0001-8966-9680
Andre RodriguesDepartment of General and Applied Biology, São Paulo State University (UNESP), Institute of Biosciences, Rio Claro, São Paulo, Brazil.ORCID 0000-0002-4164-9362
Nadine ZiemertCluster of Excellence-Controlling Microbes to Fight Infections, University of Tübingen, Tübingen, Germany.
Nicole GerardoDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-3185-6616

Funding

Deutsche Forschungsgemeinschaft (DFG) BE6922/1-1Deutsche Forschungsgemeinschaft (DFG) EXC 2124 - 390838134Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2019/03746-0Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2021/04706-1National Science Foundation (NSF) 1711545National Science Foundation (NSF) 1754595National Science Foundation (NSF) 1927411
6 · The paper itself

Abstract

The metabolic intimacy of symbiosis often demands the work of specialists. Natural products and defensive secondary metabolites can drive specificity by ensuring infection and propagation across host generations. But in contrast to bacteria, little is known about the diversity and distribution of natural product biosynthetic pathways among fungi and how they evolve to facilitate symbiosis and adaptation to their host environment. In this study, we define the secondary metabolism of

Indexed as

AntsGenome, FungalHypocrealesPhylogenySecondary MetabolismSymbiosisAnimalsBiosynthetic PathwaysEvolution, MolecularGenomicsparasitismsecondary metabolismsymbiosis

Identifiers

PMID38904377
PMCPMC11265373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.